Month: July 2021
The ‘sonoma miracle’: Sonoma’s miracle drug is now on the market
A Sonoma, California, pharmaceutical company is touting its new product, Sonoma Select.Its a powerful drug that will help treat and prevent brain cancer.And it could also save lives.The drug, named Sonoma select, has been used by some doctors for more than a decade.But it wasn’t until 2016 that it hit the market, after a breakthrough […]
Continue Reading...
How to Get a Stock That Will Last for a Long Time
A new drug maker, MARINUS Pharmaceuticals, has been granted a license to sell an insulin treatment that was developed using a technology called gene therapy.The company’s application was submitted Thursday by a regulatory committee in the United States.MARINAS patent covers the use of a gene therapy to treat multiple sclerosis.The company says the drug is […]
Continue Reading...
Inside a new drug for Alzheimer’s that won’t cost billions
An Iranian pharmaceutical company says it’s making a pill for the brain that doesn’t cost hundreds of billions of dollars.But for some Alzheimer’s patients, the drug could prove costly.And it may be a key reason why drugmakers are struggling to find a cure for the disease.“We believe that there are still many steps to take […]
Continue Reading...
When you take an antibiotic, it can be harmful
By Sarah Tew/Business Insider When you’ve been diagnosed with antibiotic-resistant bacteria, the last thing you want is to miss out on a chance to get better.So that’s exactly what some pharmaceutical companies are doing: They’re giving antibiotics that are made from synthetic biology. They’re called synthetic biosurfaces, and they’re essentially biological constructs that mimic human cells […]
Continue Reading...
When Citius Pharmaceuticals IPOed in 2015
Citius Pharma Inc. is a biopharmaceutical company that specializes in making medical devices for patients with cancer and AIDS.The company’s stock is currently trading at about $27.75.The IPO was a major catalyst for Citius, which was founded by Timber Pharmaceuticals CEO Eric Eisenegger.The startup raised $2 billion in funding, and Citius has raised a total […]
Continue Reading...
Why Vivera Pharmaceuticals wants to boost sales of its insulin injectors
Viveras Pharmaceuticals, the company that makes the insulin injector, wants to increase sales of the injectors and to attract customers with its “super-thin” packaging.The company is looking to increase its share price by around 10% this year as it looks to get into the diabetes market.It is planning to open a new US headquarters in […]
Continue Reading...
How the drug market is recovering from the opioid crisis
President Donald Trump and Senate Republicans are set to unveil a bipartisan package of opioid relief legislation Tuesday, the latest sign of bipartisan cooperation to address the crisis gripping America.The Senate Finance Committee is set to release a bill Thursday, but the package will likely be tabled for weeks.The White House and the president’s top […]
Continue Reading...
Which companies are the hottest on Wall Street?
By Andrew C. SmithThe Nasdaq, the Dow, the S&P 500 and the Nasdaq Composite have all soared since Trump took office, as the economy has grown and corporate earnings have grown.But how many stocks have surged?Here’s what you need to know about each:Corporate earnings.The top 10 U.S. companies in the Semiconductor Manufacturing and Logistics (S&.L) […]
Continue Reading...
Timber Pharmaceuticals shares are off by 0.2% after Timber Pharma’s X4 Pharmaceuticals stock falls 1.5%
Timber Pharma’s shares fell 1.4% to $12.69 at the close on Wednesday after the Australian medical equipment company’s shares plunged 1.6% to close at $12 a share.Timber’s shares have slumped more than 8% in the last two weeks, and are now trading at a record low of $8.60 a share in a market that has […]
Continue Reading...
How citius Pharmaceuticals is getting its foot in the door of the healthcare industry
Citrix has just received approval to license the first biosimilar drug, the Cetuximab, from a leading biotech firm to treat severe autoimmune diseases.The drug was developed by the San Diego-based biotech company, which is working with a number of US and European pharmaceutical companies, and will be licensed to Citrix and its partners in April.Citrix […]
Continue Reading...